These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28389940)

  • 21. The role of CD19+ CD24high CD38high and CD19+ CD24high CD27+ regulatory B cells in patients with type 1 autoimmune pancreatitis.
    Sumimoto K; Uchida K; Kusuda T; Mitsuyama T; Sakaguchi Y; Fukui T; Matsushita M; Takaoka M; Nishio A; Okazaki K
    Pancreatology; 2014; 14(3):193-200. PubMed ID: 24854615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in regulatory B cells and their relationship with rheumatoid arthritis disease activity.
    Cui D; Zhang L; Chen J; Zhu M; Hou L; Chen B; Shen B
    Clin Exp Med; 2015 Aug; 15(3):285-92. PubMed ID: 25245953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired regulatory B cells in myasthenia gravis.
    Sheng JR; Rezania K; Soliven B
    J Neuroimmunol; 2016 Aug; 297():38-45. PubMed ID: 27397074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lower proportion of CD19
    Stożek K; Grubczak K; Marolda V; Eljaszewicz A; Moniuszko M; Bossowski A
    Autoimmunity; 2020 Feb; 53(1):46-55. PubMed ID: 31790305
    [No Abstract]   [Full Text] [Related]  

  • 25. Deficit of circulating CD19
    Zaimoku Y; Patel BA; Kajigaya S; Feng X; Alemu L; Quinones Raffo D; Groarke EM; Young NS
    Br J Haematol; 2020 Aug; 190(4):610-617. PubMed ID: 32311088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic and functional alterations of regulatory B cell subsets in adult allergic asthma patients.
    Wiest M; Upchurch K; Hasan MM; Cardenas J; Lanier B; Millard M; Turner J; Oh S; Joo H
    Clin Exp Allergy; 2019 Sep; 49(9):1214-1224. PubMed ID: 31132180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic obstructive pulmonary disease is characterized by reduced levels and defective suppressive function of regulatory B cells in peripheral blood.
    Lin S; Ma Z; Huang Y; Sun Y; Yi H
    Mol Immunol; 2022 Jan; 141():87-93. PubMed ID: 34837778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating plasmablasts/plasma cells: a potential biomarker for IgG4-related disease.
    Lin W; Zhang P; Chen H; Chen Y; Yang H; Zheng W; Zhang X; Zhang F; Zhang W; Lipsky PE
    Arthritis Res Ther; 2017 Feb; 19(1):25. PubMed ID: 28183334
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional impairment of CD19
    Kim Y; Kim SY; Han SM; Payumo RM; Park K; Kim HE; Kim SH; Hyun JW; Lee E; Kim HJ
    Sci Transl Med; 2021 Dec; 13(624):eabk2132. PubMed ID: 34910550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PD-L1
    Zacca ER; Onofrio LI; Acosta CDV; Ferrero PV; Alonso SM; Ramello MC; Mussano E; Onetti L; Cadile II; Stancich MI; Taboada Bonfanti MC; Montes CL; Acosta Rodríguez EV; Gruppi A
    Front Immunol; 2018; 9():2241. PubMed ID: 30327652
    [No Abstract]   [Full Text] [Related]  

  • 31. Increased Circulating Th17 but Decreased CD4
    Qin J; Zhou J; Fan C; Zhao N; Liu Y; Wang S; Cui X; Huang M; Guan H; Li Y; Shan Z; Teng W
    Biomed Res Int; 2017; 2017():8431838. PubMed ID: 29259988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of CD19
    Zhao Q; Jung LK
    Pediatr Rheumatol Online J; 2018 Jul; 16(1):44. PubMed ID: 29973221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
    Quan C; ZhangBao J; Lu J; Zhao C; Cai T; Wang B; Yu H; Qiao J; Lu C
    J Neuroimmunol; 2015 May; 282():45-53. PubMed ID: 25903728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced peripheral blood regulatory B cell levels are not associated with the Expanded Disability Status Scale score in multiple sclerosis.
    Guo S; Chen Q; Liang X; Mu M; He J; Fang Q; Song C; Sang D
    J Int Med Res; 2018 Sep; 46(9):3970-3978. PubMed ID: 30025488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Lower Proportion of Regulatory B Cells in Patients with Henoch-Schoenlein Purpura Nephritis.
    Hu X; Tai J; Qu Z; Zhao S; Zhang L; Li M; Sun X; Jiang Y
    PLoS One; 2016; 11(3):e0152368. PubMed ID: 27030970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients.
    Heinemann K; Wilde B; Hoerning A; Tebbe B; Kribben A; Witzke O; Dolff S
    Scand J Rheumatol; 2016 Jul; 45(4):312-6. PubMed ID: 26948375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD19
    Yang M; Du C; Wang Y; Liu J
    Exp Ther Med; 2017 Oct; 14(4):3887-3893. PubMed ID: 29042997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulatory Role of B Cells and Its Subsets in Hepatitis E Virus Infection.
    Sharma M; Tripathy AS
    Biomed Res Int; 2022; 2022():7932150. PubMed ID: 36132083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased number of CD19
    Li T; Yu Z; Qu Z; Zhang N; Crew R; Jiang Y
    Mol Immunol; 2019 Aug; 112():233-239. PubMed ID: 31181422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
    Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
    Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.